These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24201067)

  • 1. Automated two-site immunofluorescent assay for the measurement of serum chromogranin A.
    Popovici T; Moreira B; Schlageter MH; Bories PN
    Clin Biochem; 2014 Jan; 47(1-2):87-91. PubMed ID: 24201067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?
    Walter T; Chardon L; Chopin-laly X; Raverot V; Caffin AG; Chayvialle JA; Scoazec JY; Lombard-Bohas C
    Eur J Cancer; 2012 Aug; 48(12):1766-73. PubMed ID: 22133573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of chromogranin B can serve as a complement to chromogranin A.
    Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E
    Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors].
    Yang XO; Li JN; Qian JM; Yang H; Chen Q; Lu L
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):124-7. PubMed ID: 21418832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A: any relevance in neuroendocrine tumors?
    Kidd M; Bodei L; Modlin IM
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):28-37. PubMed ID: 26627724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
    Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M
    Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance Evaluation of the KRYPTOR Compact PLUS Analyzer-Based B.R.A.H.M.S. CgA Ⅱ KRYPTOR Assay for Chromogranin A Measurement.
    Choi YJ; Roh J; Kim S; Lee KA; Park Y
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new immunoassay for chromogranin A measurement on the Kryptor system.
    van der Knaap RHP; Kwekkeboom DJ; Ramakers CRB; de Rijke YB
    Pract Lab Med; 2015 Apr; 1():5-11. PubMed ID: 28932793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.
    Belli SH; Oneto A; Aranda C; O'Connor JM; Domenichini E; Roca E; Méndez G; Bestani MC; Parma P; Giacomi N; Marmissolle F
    Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromogranin A and neuroendocrine tumors].
    Díaz Pérez JÁ; Currás Freixes M
    Endocrinol Nutr; 2013; 60(7):386-95. PubMed ID: 23271036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase.
    Braga F; Ferraro S; Mozzi R; Dolci A; Panteghini M
    Clin Biochem; 2013 Jan; 46(1-2):148-51. PubMed ID: 23000312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study.
    Zatelli MC; Torta M; Leon A; Ambrosio MR; Gion M; Tomassetti P; De Braud F; Delle Fave G; Dogliotti L; degli Uberti EC;
    Endocr Relat Cancer; 2007 Jun; 14(2):473-82. PubMed ID: 17639060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of three chromogranin A assays in patients with neuroendocrine tumours.
    Brehm Hoej L; Parkner T; Soendersoe Knudsen C; Grønbaek H
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):419-24. PubMed ID: 25532001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
    Massironi S; Rossi RE; Casazza G; Conte D; Ciafardini C; Galeazzi M; Peracchi M
    Neuroendocrinology; 2014; 100(2-3):240-9. PubMed ID: 25428270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.
    Monaghan PJ; Lamarca A; Valle JW; Hubner RA; Mansoor W; Trainer PJ; Darby D
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):348-52. PubMed ID: 26608723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
    Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
    Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the automated KRYPTOR chromogranin A assay with the DAKO ELISA.
    Wolf M; Riedlinger I; Lehmann R; Häring HU; Schleicher E; Peter A
    Clin Lab; 2014; 60(12):2103-6. PubMed ID: 25651748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects.
    Mosli HH; Dennis A; Kocha W; Asher LJ; Van Uum SH
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1731-5. PubMed ID: 22723311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease.
    Modlin IM; Gustafsson BI; Moss SF; Pavel M; Tsolakis AV; Kidd M
    Ann Surg Oncol; 2010 Sep; 17(9):2427-43. PubMed ID: 20217257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans.
    Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA
    Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.